TDC
TFFP

Thompson Davis & Co’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Thompson Davis & Co’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-400
Closed -$3.5K – 142
2023
Q3 		$3.5K Hold
400
– – ﹤0.01% 110
2023
Q2 		$4.7K Hold
400
– – 0.01% 117
2023
Q1 		$6.85K Hold
400
– – 0.01% 102
2022
Q4 		$10.5K Buy
+400
New +$19K 0.01% 97

Other funds holding TFFP

CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Thompson Davis & Co's TFFP Position: Q4 2023 in Review

Thompson Davis & Co sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2023, closing a stake of 400 shares — an estimated $3.5K sold.

Thompson Davis & Co first reported a position in TFFP in Q4 2022 and held it in 4 quarters. The position peaked at $10.5K in Q4 2022. 23 funds tracked by Wall St. Rank hold TFFP as of Q4 2023.

  • Thompson Davis & Co reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Thompson Davis & Co sold 400 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $3.5K.
  • Thompson Davis & Co first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • Thompson Davis & Co's TFF Pharmaceuticals, Inc. Common Stock position peaked at $10.5K in Q4 2022.
  • 23 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Thompson Davis & Co's 13F filing for Q4 2023, filed 5 Feb 2024.